Page last updated: 2024-10-30

metformin and Intermittent Claudication

metformin has been researched along with Intermittent Claudication in 5 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Intermittent Claudication: A symptom complex characterized by pain and weakness in SKELETAL MUSCLE group associated with exercise, such as leg pain and weakness brought on by walking. Such muscle limpness disappears after a brief rest and is often relates to arterial STENOSIS; muscle ISCHEMIA; and accumulation of LACTATE.

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19904 (80.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Reitz, KM1
Althouse, AD1
Forman, DE1
Zuckerbraun, BS1
Vodovotz, Y1
Zamora, R1
Raffai, RL1
Hall, DE1
Tzeng, E1
CHAKRABARTI, R2
HOCKING, ED2
FEARNLEY, GR3
Laursen, B1
Gormsen, J1

Trials

2 trials available for metformin and Intermittent Claudication

ArticleYear
MetfOrmin BenefIts Lower Extremities with Intermittent Claudication (MOBILE IC): randomized clinical trial protocol.
    BMC cardiovascular disorders, 2023, 01-21, Volume: 23, Issue:1

    Topics: Diabetes Mellitus, Type 2; Humans; Intermittent Claudication; Lower Extremity; Metformin; Peripheral

2023
Fibrinolytic effects of diguanides plus ethyloestrenol in occlusive vascular disease.
    Lancet (London, England), 1967, Nov-11, Volume: 2, Issue:7524

    Topics: Adult; Aged; Angina Pectoris; Biguanides; Blood Coagulation Tests; Cholesterol; Ethylestrenol; Femal

1967

Other Studies

3 other studies available for metformin and Intermittent Claudication

ArticleYear
FIBRINOLYTIC EFFECT OF METFORMIN IN CORONARY-ARTERY DISEASE.
    Lancet (London, England), 1965, Aug-07, Volume: 2, Issue:7406

    Topics: Arteries; Biomedical Research; Blood Coagulation Tests; Cholesterol; Coronary Artery Disease; Corona

1965
Pharmacological enhancement and short-term stimulation of blood fibrinolytic activity.
    Scandinavian journal of haematology, 1969, Volume: 6, Issue:6

    Topics: Adolescent; Adult; Aged; Aminocaproates; Anticholesteremic Agents; Arteriosclerosis; Arthritis, Rheu

1969
Pharmacological fibrinolysis.
    Bristol medico-chirurgical journal (1963), 1969, Volume: 84, Issue:312

    Topics: Aged; Androsterone; Anticholesteremic Agents; Butyrates; Chlorpropamide; Coronary Disease; Ethylestr

1969